MedPath

survey of covid 19 impact on Surgeries

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2022/03/040723
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Data from GI and HPB Surgery centres across the country willing to participate in the study will be included.

Exclusion Criteria

Not operated patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of gastrointestinal and hepatopancreaticobiliarycentresfunctioning as Covid care centres.Timepoint: 12 month
Secondary Outcome Measures
NameTimeMethod
-Duration of interruption of cancer care services during the active covid phase. <br/ ><br>-Proportional decrease in gastrointestinal and hepatopancreaticobiliary cancer registrations, operations and minimal access surgeries. <br/ ><br>-Outcome of gastrointestinal and hepatopancreaticobiliary cancer surgeries in covid positive patients. <br/ ><br>-Major morbidity and mortality rates in comparison to pre-covid era. <br/ ><br> <br/ ><br>Timepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath